SCHEMBL6983417

SCHEMBL6983417

[O]Cc1cccc(CO)n1

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PGK1 P00558 1/20 0.45
PGK2 P07205 1/20 0.45
CCR1 P32246 1/20 0.44
NPSR1 Q6W5P4 1/20 0.41
HRH4 Q9H3N8 1/20 0.39
GRIN2D O15399 1/20 0.38
GRIN3B O60391 1/20 0.38
GRIN1 Q05586 1/20 0.38
GRIN2A Q12879 1/20 0.38
GRIN2B Q13224 1/20 0.38
GRIN2C Q14957 1/20 0.38
GRIN3A Q8TCU5 1/20 0.38
KCNH2 Q12809 3/20 0.37
ADORA2A P29274 3/20 0.35
HSD11B1 P28845 1/20 0.35
MPO P05164 1/20 0.35
ADORA1 P30542 1/20 0.33
NOTUM Q6P988 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL486201 0.87 CCR1 (0.55) PGK1PGK2CCR1NPSR1HRH4
Acetic Acid SCHEMBL6984469 0.79 NPSR1 (0.53) PGK1PGK2CCR1NPSR1HRH4
SCHEMBL11576989 0.77 NPSR1 (0.47) PGK1PGK2CCR1NPSR1HRH4
Diamidophosphate SCHEMBL10935056 0.77 PGK1 (0.57) PGK1PGK2CCR1NPSR1HRH4
SCHEMBL942940 0.76 CCR1 (0.44) PGK1PGK2CCR1NPSR1HRH4
SCHEMBL2935700 0.76
SCHEMBL12335647 0.76
SCHEMBL5104176 0.76 CCR1 (0.44) PGK1PGK2CCR1NPSR1HRH4
SCHEMBL31098473 0.76 CCR1 (0.44) PGK1PGK2CCR1NPSR1HRH4
SCHEMBL29028968 0.76 CCR1 (0.44) PGK1PGK2CCR1NPSR1HRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0985671-B1 PYRIDOCARBAZOLE DERIVATIVES HAVING cGMP-PDE INHIBITORY EFFECT MOCHIDA PHARM CO LTD (JP) 2003-04-02 EP disclosed
US-6476021-B1 Compounds having cGMP-PDE inhibitory effect MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2002-11-05 US disclosed
US-6197768-B1 THERAPY, PREVENTION ISCHEMIC HEART DISEASE MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2001-03-06 US disclosed
EP-1048666-A1 NOVEL COMPOUNDS HAVING cGMP-PDE INHIBITORY EFFECT MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2000-11-02 EP disclosed
EP-0992240-A1 THERAPEUTIC AGENT FOR ERECTION FAILURE MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2000-04-12 EP disclosed
EP-0985671-A1 PYRIDOCARBAZOLE DERIVATIVES HAVING cGMP-PDE INHIBITORY EFFECT MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2000-03-15 EP disclosed
US-6018046-A SELECTIVE ACTION IN INHIBITING CYCLIC GMP-PHOSPHODIESTERASE (CGMP-PDE); PHARMACEUTICALS FOR TREATING DISEASES AGAINST WHICH THE INHIBITORY ACTION IS EFFECTIVE, SUCH AS PULMONARY HYPERTENSION MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2000-01-25 US disclosed